Neonc Technologies (NASDAQ:NTHI) CEO Amir Heshmatpour Purchases 37,000 Shares of Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour purchased 37,000 shares of Neonc Technologies stock in a transaction dated Friday, September 11th. The shares were bought at an average cost of $3.67 per share, for a total transaction of $135,790.00. Following the transaction, the chief executive officer directly owned 3,133,000 shares of the company’s stock, valued at approximately $11,498,110. The trade was a 1.20% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Neonc Technologies Price Performance

Shares of Neonc Technologies stock opened at $3.78 on Tuesday. Neonc Technologies Holdings, Inc. has a fifty-two week low of $3.01 and a fifty-two week high of $12.99. The business has a 50-day moving average price of $4.06 and a 200 day moving average price of $5.32.

Neonc Technologies (NASDAQ:NTHI) last announced its quarterly earnings data on Monday, August 10th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.46).

Analyst Ratings Changes

NTHI has been the topic of several research reports. Maxim Group started coverage on Neonc Technologies in a research report on Monday, May 18th. They set a “buy” rating and a $20.00 price target on the stock. Alliance Global Partners started coverage on shares of Neonc Technologies in a research note on Tuesday, May 19th. They set a “buy” rating and a $13.00 target price for the company. Weiss Ratings raised shares of Neonc Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 31st. Wall Street Zen downgraded shares of Neonc Technologies from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Finally, BTIG Research reaffirmed a “buy” rating and issued a $15.00 price target on shares of Neonc Technologies in a report on Tuesday, September 8th. Three research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $16.00.

Institutional Trading of Neonc Technologies

Several hedge funds have recently made changes to their positions in NTHI. Global Retirement Partners LLC acquired a new position in Neonc Technologies during the 2nd quarter valued at approximately $126,000. BlackRock Inc. acquired a new stake in Neonc Technologies in the second quarter worth $815,000. Westmount Partners LLC increased its position in Neonc Technologies by 355.2% in the second quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock worth $893,000 after buying an additional 153,858 shares during the period. Finally, Bank of America Corp DE bought a new stake in Neonc Technologies in the second quarter valued at $1,017,000.

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.